| Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study X Li, C Mukandavire, ZM Cucunubá, SE Londono, K Abbas, HE Clapham, ... The Lancet 397 (10272), 398-408, 2021 | 194 | 2021 |
| Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world J Toor, S Echeverria-Londono, X Li, K Abbas, ED Carter, HE Clapham, ... Elife 10, e67635, 2021 | 71 | 2021 |
| Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries KAM Gaythorpe, K Abbas, J Huber, A Karachaliou, N Thakkar, K Woodruff, ... Elife 10, e67023, 2021 | 68 | 2021 |
| Vaccine equity in low and middle income countries: a systematic review and meta-analysis HA Ali, AM Hartner, S Echeverria-Londono, J Roth, X Li, K Abbas, ... International journal for equity in health 21 (1), 82, 2022 | 66 | 2022 |
| How can the public health impact of vaccination be estimated? S Echeverria-Londono, X Li, J Toor, MJ de Villiers, S Nayagam, TB Hallett, ... BMC Public Health 21, 1-12, 2021 | 20 | 2021 |
| Estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030 X Li, C Mukandavire, ZM Cucunubá, K Abbas, HE Clapham, M Jit, ... MedRxiv, 19004358, 2019 | 14 | 2019 |
| COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery J Toor, X Li, M Jit, CL Trotter, S Echeverria-Londono, AM Hartner, J Roth, ... vaccine 40 (31), 4142-4149, 2022 | 10 | 2022 |
| Vaccine impact modelling consortium, estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030 X Li, C Mukandavire, ZM Cucunubá, K Abbas, HE Clapham, M Jit, ... Lancet 397, P398-P408, 2019 | 7 | 2019 |
| Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: multimodel comparative analysis of … K Gaythorpe, K Abbas, J Huber, A Karachaliou, N Thakkar, K Woodruff, ... medRxiv, 2021.01. 25.21250489, 2021 | 3 | 2021 |
| Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy SS Kumar, AM Hartner, A Chandran, KAM Gaythorpe, X Li BMC Public Health 23 (1), 2351, 2023 | 2 | 2023 |
| Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study AM Hartner, X Li, S Echeverria-Londono, J Roth, K Abbas, M Auzenbergs, ... The Lancet Global Health 12 (4), e563-e571, 2024 | 1 | 2024 |
| COVID-19-related disruption and resiliency in immunisation activities in LMICs: a rapid review AM Hartner, X Li, KAM Gaythorpe medRxiv, 2023.06. 12.23291133, 2023 | 1 | 2023 |
| Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa S Echeverria-Londono, AM Hartner, X Li, J Roth, A Portnoy, AN Sbarra, ... Vaccine 40 (47), 6806-6817, 2022 | 1 | 2022 |
| COVID-19 Related Immunisation Disruptions from 2020-2030: Projecting Health Impact and Mitigation Strategies for 14 Pathogens Across 112 Low-and Middle-Income Countries AM Hartner, X Li, S Echeverria-Londono, J Roth, K Abbas, M Auzenbergs, ... | | 2023 |
| Vaccine Equity in Low and Middle Income Countries: A Systematic Review and Meta-analysis (preprint) H Ali, AM Hartner, S Echeverria-Londono, J Roth, X Li, K Abbas, ... | | 2022 |
| Vaccines can save children with non-preventable diseases–Authors' reply KAM Gaythorpe, J Toor, S Echeverria-Londono, X Li, NM Ferguson The Lancet 397 (10291), 2251, 2021 | | 2021 |
